Cartesian Therapeutics, Inc. · NASDAQ:RNAC
Cartesian Therapeutics, Inc. shareholders
As of Jun 30, 2026, 90 institutions reported holding Cartesian Therapeutics, Inc., 28.7% of its shares. Largest: Squarepoint Ops LLC, BlackRock and Vanguard. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Cartesian Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| Squarepoint Ops LLC | 2.25M | 7.5% | +16,133 | Aug 14, 2026 |
| BlackRock | 819K | 2.7% | +220K | Aug 7, 2026 |
| Vanguard | 739K | 2.4% | +197K | Aug 13, 2026 |
| 683 Capital Management, LLC | 650K | 2.1% | +320K | Aug 14, 2026 |
| Fidelity | 368K | 1.2% | −431K | Aug 13, 2026 |
| Geode Capital | 357K | 1.2% | +92,831 | Aug 12, 2026 |
| AQR Capital Management LLC | 356K | 1.2% | +272K | Aug 14, 2026 |
| Millennium | 310K | 1.0% | +25,570 | Aug 14, 2026 |
| Two Sigma | 296K | 0.98% | +129K | Aug 14, 2026 |
| State Street | 249K | 0.82% | +48,875 | Aug 7, 2026 |